How big is the financial burden of hepatitis B to society? A cost-of-illness study of hepatitis B infection in Singapore
10.1111/j.1365-2893.2008.01042.x
Saved in:
Main Authors: | Ong, S.C., Lim, S.G., Li, S.C. |
---|---|
Other Authors: | PHARMACY |
Format: | Article |
Published: |
2014
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/106002 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Medical and economic burden of chronic hepatitis B patients at Queen Savang Vadhana Memorial Hospital
by: Chuenrutai Yeekian
Published: (2023) -
The economics of treating chronic hepatitis B in Asia
by: Dan, Y.Y., et al.
Published: (2011) -
Pharmacoeconomics and health outcomes research for Hepatitis B virus infection in Singapore
by: ONG SIEW CHIN
Published: (2010) -
The majority of hepatitis B carriers are not on regular surveillance in Singapore
by: Wai, C.-T., et al.
Published: (2014) -
Molecular characterization, evolution and cross-species transmission study in severe combined immunodeficiency transgenic mice with human hepatocytes of gibbon and orangutan hepatitis B virus
by: Pattaratida Sa-nguanmoo
Published: (2012)